Duloxetine Delayed-Release Capsules USP recall: Failed Dissolution
Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202…
Why was Duloxetine Delayed-Release Capsules USP recalled?
Failed Dissolution Specification
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: G602051, Exp. 12/2017
- Product
- Duloxetine Delayed-Release Capsules USP, 30 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202…
- Recalling firm
- Lupin Pharmaceuticals Inc.
- Quantity
- 111,648 units
- Distribution
- Nationwide within the United States
- Recall date
- December 6, 2017
- Classification
- Class III
- Status
- Terminated
- Agency
- FDA (drug)